Evaluation of Interferon Alpha-2b and Thalidomide in Patients With Disseminated Malignant Melanoma, Phase II
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Thalidomide
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 Jun 2013 Biomarkers information updated
- 20 Apr 2006 Status changed from in progress to completed.
- 11 Sep 2005 New trial record.